The <i>hOCT1</i> and <i>ABCB1</i> polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemiaSara Galimberti, Antonello Di Paolo, E. Arrigoni et al.|Oncotarget|2017Cited by 13